Paclitaxel, 5-fluorouracil, and folinic acid in metastatic breast cancer: BRE-26, a phase II trial

被引：0
|
作者：
Johnson, DH
Paul, D
Hande, KR
机构：
来源：
SEMINARS IN ONCOLOGY | 1997年 / 24卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S22 / S25
页数：4
相关论文
共 50 条
  • [1] An alternating regimen of irinotecan/5-fluorouracil/folinic acid and oxaliplatin/5-fluorouracil/folinic acid in metastatic colorectal cancer: A phase II trial
    Ferrari, V
    Valcamonico, F
    Amoroso, V
    Simoncini, E
    Vassalli, L
    Marpicati, P
    Rangoni, G
    Grisanti, S
    Pasinetti, N
    Marini, G
    ONCOLOGY, 2005, 69 (04) : 283 - 289
  • [2] Phase II trial of chronomodulated infusion of 5-fluorouracil and folinic acid in metastatic colorectal cancer
    Cure, H
    Chevalier, V
    Pezet, D
    Bousquet, J
    Focan, C
    Levi, F
    Garufi, C
    Chipponi, J
    Chollet, P
    ANTICANCER RESEARCH, 2000, 20 (6C) : 4649 - 4653
  • [3] Paclitaxel/5-fluorouracil/leucovorin in metastatic breast cancer: A Vanderbilt cancer center phase II trial
    Nicholson, B
    Paul, D
    Shyr, Y
    Garrett, M
    Hande, KR
    Johnson, DH
    SEMINARS IN ONCOLOGY, 1997, 24 (04) : 20 - 23
  • [4] PHASE-II TRIAL OF 5-FLUOROURACIL AND FOLINIC ACID IN THE TREATMENT OF ADVANCED BREAST-CANCER
    FINE, S
    ERLICHMAN, C
    KAIZER, L
    WARR, D
    GADALLA, T
    BREAST CANCER RESEARCH AND TREATMENT, 1994, 30 (02) : 205 - 209
  • [5] Phase II multicenter trial of a weekly paclitaxel, 5-fluorouracil and leucovorin regimen in patients with metastatic breast cancer
    Loesch, DM
    Robert, NJ
    Keller, AM
    Young, JA
    Rohrbaugh, TM
    Smyth, AC
    SEMINARS IN ONCOLOGY, 1999, 26 (01) : 32 - 32
  • [6] Weekly paclitaxel, 5-fluorouracil and folinic acid with granulocyte colony-stimulating factor support in metastatic breast cancer patients:: a phase II study
    Nistico, Cecilia
    Bria, Emilio
    Agostara, Biagio
    Barni, Sandro
    Colella, Elvira
    Frontini, Luciano
    D'Ottavio, Anna Maria
    Cuppone, Federica
    Valenza, Roberto
    Sperduti, Isabella
    Izzo, Fiorentino
    Terzoli, Edmondo
    ANTI-CANCER DRUGS, 2006, 17 (03) : 345 - 351
  • [7] Preclinical and clinical study results of the combination of paclitaxel and 5-fluorouracil/folinic acid in the treatment of metastatic breast cancer
    Klaassen, U
    Harstrick, A
    Wilke, H
    Seeber, S
    SEMINARS IN ONCOLOGY, 1996, 23 (01) : 44 - 47
  • [8] Chronotherapy with 5-fluorouracil, folinic acid and carboplatin for metastatic colorectal cancer; an interesting therapeutic index in a phase II trial
    Focan, C
    Kreutz, F
    Focan-Henrard, D
    Moeneclaey, N
    EUROPEAN JOURNAL OF CANCER, 2000, 36 (03) : 341 - 347
  • [9] A phase II trial of paclitaxel and weekly 24 h infusion of 5-fluorouracil folinic acid in patients with advanced gastric cancer
    Bokemeyer, C
    Lampe, CS
    Clemens, MR
    Hartmann, JT
    Quietzsch, D
    Forkmann, L
    Kollmannsberger, C
    Kanz, L
    ANTI-CANCER DRUGS, 1997, 8 (04) : 396 - 399
  • [10] Phase I/II study with paclitaxel in combination with weekly high-dose 5-fluorouracil folinic acid in the treatment of metastatic breast cancer: An interim analysis
    Klaassen, U
    Wilke, H
    Philippou, P
    Strumberg, PD
    Harstrick, A
    Eberhardt, W
    Becher, R
    Diergarten, K
    Seeber, S
    SEMINARS IN ONCOLOGY, 1995, 22 (06) : 7 - 11
12345